Actavis Blasts USPTO Decision In Opana Row
By Daniel Langhorne ( July 29, 2015, 9:12 PM EDT) -- Actavis Inc. on Tuesday asked a New York federal judge overseeing Endo Pharmaceuticals Inc.'s case accusing it and several other generics manufacturers of infringing its patent for painkiller Opana ER to disregard a U.S. Patent and Trademark Office decision upholding Endo's patent, arguing the administrative ruling has no bearing on the pending civil case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.